Clarify that compounded drugs with the same active ingredient as an approved medicine are considered 'essentially a copy' unless clinically different for a specific patient.
I will clarify that compounded drugs with the same active ingredient as an approved medicine are considered 'essentially a copy' unless clinically different for a specific patient.
Occurrences
Evidence
The Senate press release says Banks introduced the SAFE Drugs Act and that it would "clarify that compounded drugs with the same active ingredient as an approved medicine are considered 'essentially a copy' unless clinically different for a specific patient."
Banks's Senate legislation page lists S.3794, the SAFE Drugs Act of 2026, with latest action: "Read twice and referred to the Committee on Health, Education, Labor, and Pensions."
Assessments
Banks introduced the SAFE Drugs Act in the same federal Senate term, and the bill text reportedly contains the promised clarification about compounded drugs being considered essentially copies unless clinically different for a specific patient. However, the available evidence shows only introduction and referral to the Senate HELP Committee, with no enactment or implemented federal policy change. That is a serious legislative attempt but not delivery of the promised outcome.